The newest and most promising therapies for challenging cancers are adopting molecular biology strategies. Brain tumors are especially problematic because their location impedes patient function and presents formidable barriers to surgical treatments. But new molecular approaches show promise. <\/p>\n
A series of new techniques from viruses genetically trained to attack the tumor to genetic modifications of immune cells to new types of monoclonal antibodies represent a few of the new tricks researchers are now deploying in the fight against these deadly conditions. <\/p>\n
Dr. Duane Mitchell is a Professor at the University of Florida. He is a neurosurgeon that is discovering and refining the leading next-generation therapies. In todays podcast, he shares his expertise onthe new types of technologies and the promise they bring. <\/p>\n
Website: Dr. Duane Mitchell and the UF Brain Tumor Immunotherapy Program <\/p>\n
Follow Talking Biotech on Twitter@TalkingBiotech <\/p>\n
FollowKevin Folta on Twitter @kevinfolta|Facebook:Facebook.com\/kmfolta\/| Lab website:Arabidopsisthaliana.com| All funding: Kevinfolta.com\/transparency <\/p>\n
Stitcher| iTunes|Player FM|TuneIn <\/p>\n
Visit Kevin Foltas Talking Biotech <\/p>\n
<\/p>\n
Go here to read the rest: The newest and most promising therapies for challenging cancers are adopting molecular biology strategies. Brain tumors are especially problematic because their location impedes patient function and presents formidable barriers to surgical treatments. But new molecular approaches show promise. Continue reading
\nTalking Biotech: Florida neurosurgeon Duane Mitchell on how genetic engineering opens doors in cancer fight - Genetic Literacy Project<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"